LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System (opens in new tab)

BERN, SWITZERLAND, June 23, 2026 (Newswire.com) – LEM Surgical Inc., a pioneer in advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted an additional 510(k) clearance for its Dynamis Robotic Surgical System. This landmark milestone introduces further capabilities to the groundbreaking, surgical humanoid architecture that is focused on the global orthopedic and spine surgery market.